HLA-G and lymphoproliferative disorders (Q35621791)

9 August 2017

1 reference

title

HLA-G and lymphoproliferative disorders (English)

1 reference

9 August 2017

7

Xavier Leleu

0 references

Yasmine Sebti

object named as

Yasmine Sebti

3

0 references

Céline Pangault

object named as

Céline Pangault

5

0 references

Thierry Facon

9

object named as

Thierry Facon

1 reference

9 August 2017

Laurence Amiot

1

1 reference

9 August 2017

Gaëlle Le Friec

2

1 reference

9 August 2017

Bernard Drénou

4

1 reference

9 August 2017

Valérie Guilloux

6

1 reference

9 August 2017

Marc Bernard

8

1 reference

9 August 2017

Renée Fauchet

10

1 reference

9 August 2017

language of work or name

1 reference

1 October 2003

1 reference

Seminars in Cancer Biology

9 August 2017

published in

1 reference

9 August 2017

volume

13

1 reference

9 August 2017

issue

5

1 reference

9 August 2017

page(s)

379-385

1 reference

Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

Identification of a Thymic Epithelial Cell Subset Sharing Expression of the Class Ib HLA-G Molecule with Fetal Trophoblasts

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

HLA Class I Expression on the Materno‐Fetal Interface

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

A class I antigen, HLA-G, expressed in human trophoblasts

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

Polymorphism of HLA-G gene and protein

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells.

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily.

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

Resistance of HLA-G and HLA-A2 transfectants to lysis by decidual NK cells

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

Soluble HLA class I/CD8 ligation triggers apoptosis in EBV-specific CD8 cytotoxic T lymphocytes by Fas/Fas-ligand interaction

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8 cells by interacting with CD8

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

Soluble HLA-G protein secreted by allo-specific CD4 T cells suppresses the allo-proliferative response: a CD4 T cell regulatory mechanism

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: implications for myoblast transplantation and gene therapy

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

HLA-G transcription studies during the different stages of normal and malignant hematopoiesis

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

Distribution of HLA-G alternative mRNAs including soluble forms in normal lymphocytes and in lymphoid cell-derived leukemia

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

HLA-G class I gene expression in normal and malignant hematopoietic cells

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

Major histocompatibility complex abnormalities in non-Hodgkin lymphomas

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

Detection of soluble HLA-G molecules in plasma and amniotic fluid

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

Serum beta2microglobulin and survival duration in multiple myeloma: a simple reliable marker for staging

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

Serum beta-2-microglobulin binding activity in monoclonal gammopathy: Correlative study and clinical significance

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

Molecular mechanisms controlling constitutive and IFN-gamma-inducible HLA-G expression in various cell types.

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

Transcriptional regulation of the MHC class Ib genes HLA-E, HLA-F, and HLA-G.

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

HLA-G transactivation by cAMP-response element-binding protein (CREB). An alternative transactivation pathway to the conserved major histocompatibility complex (MHC) class I regulatory routes

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

Lung macrophages and dendritic cells express HLA-G molecules in pulmonary diseases

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells?

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

HLA-G Expression in Atopic Dermatitis

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection.

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

In vivo production of interleukin-10 by malignant cells in AIDS lymphomas.

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

Expression analysis of classic and non-classic HLA molecules before interferon alfa-2b treatment of melanoma

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

Implication of HLA-G molecule in heart-graft acceptance.

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression.

1 reference

https://api.crossref.org/works/10.1016/S1044-579X(03)50029-4

7 January 2021

10.1016/S1044-579X(03)00029-4

Identifiers

DOI

1 reference

9 August 2017

1 reference